EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Nemaura Medical's Enterprise Value is $21.59 Mil.
Nemaura Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-4.98 Mil. Therefore, Nemaura Medical's EV-to-EBIT for today is -4.33.
The historical rank and industry rank for Nemaura Medical's EV-to-EBIT or its related term are showing as below:
NMRD'
s EV-to-EBIT Range Over the Past 10 Years
Min: -16.78 Med: -5.5 Max: -2.11
Current: -4.33
During the past 10 years, the highest EV-to-EBIT of Nemaura Medical was -2.11. The lowest was -16.78. And the median was -5.50.
NMRD's EV-to-EBIT is ranked worse than 100% of 465
companies
in the Medical Devices & Instruments industry
Industry Median: 19.86
vs NMRD: -4.33
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Nemaura Medical's Enterprise Value for the quarter that ended in Dec. 2023 was $25.83 Mil.
Nemaura Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-4.98 Mil. Nemaura Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -19.29%.
Nemaura Medical EV-to-EBIT Historical Data
The historical data trend for Nemaura Medical's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nemaura Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nemaura Medical EV-to-EBIT Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Nemaura Medical's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Nemaura Medical's EV-to-EBIT falls into.
Nemaura Medical EV-to-EBIT Calculation
Nemaura Medical's EV-to-EBIT for today is calculated as:
Nemaura Medical's current Enterprise Value is $21.59 Mil.
Nemaura Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.98 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nemaura Medical (OTCPK:NMRD) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Nemaura Medical's Enterprise Value for the quarter that ended in Dec. 2023 was $25.83 Mil.
Nemaura Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.98 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nemaura Medical EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Nemaura Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Nemaura Medical (Nemaura Medical) Business Description
Nemaura Medical Inc is a medical technology company developing sugarBEAT as a non-invasive, affordable, and flexible Continuous Glucose Monitor (CGM) designed for people with diabetes and pre-diabetics to manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading. SugarBEAT consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with an app displaying glucose readings at five-minute intervals for periods up to 24 hours.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NMRD has been successfully added to your 